Structural basis for topoisomerase VI inhibition by the anti-Hsp90 drug radicicol

By Corbett Kevin D.   Berger James M.  

Nucleic Acids Research, Vol. 34, Iss. 15, 2006-09 ,pp. : 4269-4277

Oxford University Press

Access to resources Recommend Favorite

Inhibition of Hsp90 acts synergistically with topoisomerase II poisons to increase the apoptotic killing of cells due to an increase in topoisomerase II mediated DNA damage

By Barker Catherine R.   McNamara Anne V.   Rackstraw Stephen A.   Nelson David E.   White Mike R.   Watson Alastair J. M.   Jenkins John R.  

Nucleic Acids Research, Vol. 34, Iss. 4, 2006-01 ,pp. : 1148-1157

Oxford University Press

Access to resources Recommend Favorite

Induction of unique structural changes in guanine-rich DNA regions by the triazoloacridone C-1305, a topoisomerase II inhibitor with antitumor activities

By Lemke Krzysztof   Wojciechowski Marcin   Laine William   Bailly Christian   Colson Pierre   Baginski Maciej   Larsen Annette K.   Skladanowski Andrzej  

Nucleic Acids Research, Vol. 33, Iss. 18, 2005-01 ,pp. : 6034-6047

Oxford University Press

Access to resources Recommend Favorite

Inhibition of translesion DNA polymerase by archaeal reverse gyrase

By Valenti Anna  

Nucleic Acids Research, Vol. 37, Iss. 13, 2009-07 ,pp. : 4287-4295

Oxford University Press

Access to resources Recommend Favorite

Inhibitory Effects of Cholesterol Derivatives on DNA Polymerase and Topoisomerase Activities, and Human Cancer Cell Growth

By Ishimaru Chisato  

Lipids, Vol. 43, Iss. 4, 2008-04 ,pp. : 373-382

Springer Publishing Company

Access to resources Recommend Favorite